chrisvoncsefalvay/vaers-outcomes huggingface dataset:
CONFIRMED COVID-19 INFECTION; MILD HEADACHE; SORENESS AT INJECTION SITE; This spontaneous report received from a vaccine facility concerned a 35 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802072, and expiry: UNKNOWN) dose was not reported, administered on 12-MAR-2021 to left deltoid for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 14-MAR-2021, the subject experienced mild headache. On 14-MAR-2021, the subject experienced soreness at injection site. On 21-MAR-2021 13:35, Laboratory data included: COVID-19 PCR test (NR: not provided) Positive. On 21-MAR-2021 22:41, the subject experienced confirmed covid-19 infection. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from mild headache on 14-MAR-2021, and soreness at injection site on MAR-2021, and the outcome of confirmed covid-19 infection was not reported. This report was non-serious.
After two day I had painful muscle spasm, lasting for 4 or 5 days. Muscle aches for 8 weeks and still on going.
Within the first 10 mins  of the shot I had sharp chest pains, hives on my chest, face and neck, very sore neck (left side) from behind my ear to left clavicle and numbness on my jaw. I was instructed by my doctor to go to the nearest emergency. At the ER,  I got light headed.   11/18 - had white spots on my tonsils and believed it was strep. Got swab and a culture test  and it came back negative.
Patient developed bilateral face weakness with laboratory testing consistent with a subtype of Guillain-Barre Syndrome and is receiving treatment for this diagnosis currently in the hospital.
13 year old received a Pfizer pediatric dose instead of the correct Adult Pfizer vaccine. No adverse effects from vaccine administration.
No other AE; Improper storage of product in use; This spontaneous report was received from medical assistant and refers to a 4-year-old patient of unknown gender. The patient's medical history and concurrent conditions were not reported. Concomitant medications included sterile diluent.  On 17-MAY-2023, the patient started was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) injection, unk, administered for prophylaxis (strength, and route of administration were not provided), lot #U039722, expiration date: 15-DEC-2023 (discrepancy: lot# reported also as U0397722 and this lot# is not valid for varicella virus vaccine live [oka/merck] [VARIVAX]) (product storage error). Administrated varicella virus vaccine live (oka/merck) (VARIVAX) was stored at 12.45 Fahrenheit degrees (F) for 20 minutes, previous temperature excursion was reported: 42.31 F for 36 hours and 35 minutes. There were no adverse events reported (no adverse event).  This is one of several reports received from the same reporter.
It was reported that a pt (7of7) rec'd a TD adult vaccination, date not specified. Reportedly sometime after the vaccination the pt developed flu-like symptoms and a local reaction, red swollen arm. Further information is requested.
Left leg swelling after pentacel vaccine Leg swollen noted last ngiht and continue this am Mild redness, not tender No fever  Normal activity  No vomiting Only received pentacel vaccine on 12/12/22
Patient presented and said her arm from shoulder to elbow was red and had a big amount of swelling and wished to let us know. Some bruising as well.
With having MS, I have severe anxiety and I was anxious  before going in- numbness and tingling in my legs and tingling on my tongue. Took Benadryl - tongue tingling went away and the legs tingling and numbness was the same  and started getting worse - they monitored my vitals and everything looked good and numbness remained. I had a driver and they allowed me to leave due to the Benadryl  _ just took that one dose of Benadryl (didn't take anymore after that) and then the numbness in my legs remained for about two and a half weeks. I used a cane for two days. I had a fever and chills that first night, body aches and injection site pain and severe fatigue and those symptoms lasted one day except fatigue was for three days. The day after the shot was the worse of the symptoms. They followed up with me that evening and they followed up with me at work.  I had the next dose - February 4, 2021 and experienced everything except the numbness in the tongue. Informal doctor visit because I work there.
This spontaneous report as received from an other health professional and a certified medical assistant (C.M.A.) refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 10-AUG-2015, the patient was vaccinated with a first dose of improperly stored GARDASIL injection (intramuscularly, lot # K007828, expiration date 02-MAR-2017, dose was not reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
The client stated he felt like he had "the flu." He said he had diarrhea, nausea, and a low-grade fever for "a couple of days." He denies having chills. He said the entire upper half of his left arm (the arm the vaccine was administered in) was "red and splotchy" for a week after administration. The client stated he was so ill he missed two days of work. He stated he took Ibuprofen 2 tablets every six hours regularly the entire time he had symptoms. He stated he did not change medications or was around anyone who had similar symptoms. He did not seek medical treatment or see a doctor because  he "figured a doctor would not be able to do anything different" for him. He said he is feeling better and has fully recovered.
child received HPV and had fingerstick for hemoglobin.  left exam room and was sitting alone in conference room began to feel light headed and was heard to hit her head on desk.  She had not eaten breakfast.  Child was kept on the floor and given oxygen and felt better.  She again sat up and shortly afterwards became pale and light headed again and was laid down on the floor.  She was sent to the ER for further evaluation and management since head trauma was unwitnessed
Sweating; Sore arm; 100.8 degree F fever; Chills; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 03-Mar-2021 and was forwarded to Moderna on 04-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating), PAIN IN EXTREMITY (Sore arm), PYREXIA (100.8 degree F fever) and CHILLS (Chills) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.   On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced HYPERHIDROSIS (Sweating), PAIN IN EXTREMITY (Sore arm), PYREXIA (100.8 degree F fever) and CHILLS (Chills). At the time of the report, HYPERHIDROSIS (Sweating), PAIN IN EXTREMITY (Sore arm), PYREXIA (100.8 degree F fever) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Mar-2021, Body temperature: 100.8 degree f High.
Strong pain in left arm from shoulder to wrist; Immediately following arm went numb; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Strong pain in left arm from shoulder to wrist) and HYPOAESTHESIA (Immediately following arm went numb) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In November 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2021, the patient experienced PAIN IN EXTREMITY (Strong pain in left arm from shoulder to wrist) and HYPOAESTHESIA (Immediately following arm went numb). At the time of the report, PAIN IN EXTREMITY (Strong pain in left arm from shoulder to wrist) and HYPOAESTHESIA (Immediately following arm went numb) outcome was unknown. Not Provided    No concomitant information was provided by the reporter.  No treatment information was provided.   This case was linked to MOD-2021-387323 (Patient Link).   Reporter did not allow further contact
4cm x 4 1/2cm irregular erythematous indurated urticaria like reaction non tender;no fever;only local not systemic;
I have high levels of absolute nucleated RBC and nucleated RBC; This is a spontaneous report from a contactable consumer reporting for herself.    A 60-years-old female patient received bnt162b2 (BNT162B2), dose 2 and dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation.  Medical history included autoimmune disorder. The patient's concomitant medications were not reported. The patient experienced high levels of absolute nucleated RBC and nucleated RBC  on an unspecified date with outcome of unknown. The patient underwent lab tests and procedures which included red blood cell count: high. No follow-up attempts are needed; information about lot/batch number cannot be obtained.
-abnormal rhythmic left arm movements after 6 mo imm. -began at approx 5pm 1/14/10: lasted 20-30 sec each. -low grade fever -"zoned out" at approx 5 pm 1/14/10
Information has been received from a consumer concerning her 32 month old, also reported as 24 months, daughter with no pertinent medical history, drug reactions or allergies reported, who on 25-OCT-2009 was vaccinated with a 0.5 mL first dose of RECOMBIVAX HB "in the leg, not SQ like the live vaccines but a regular injection" (lot # unknown). No concomitant medication reported. The consumer reported that "14 days after vaccination", on 08-DEC-2009, the patient experienced a rash on the hands. An unspecified dermatologist who said that the rash could have been eczema or contact dermatitis. The consumer stated that around that time, the patient was also stuck in a couple of words and her mother was not sure if the patient was going through a stage with her talking. The consumer reported that the patient had been playing in the leaves so the rash experienced possibly could have been from the leaves. The consumer reported that there was no fever or hives. No lab diagnostic studies performed. The patient sought medical attention in the dermatologist's office. It was reported that "1-2 weeks after rash occurred", on approximately 22-DEC-2009, the patient recovered from the rash on the hands which could have been eczema or contact dermatitis. At the time of the report, the status of the stuck on word was unknown. Follow up information has been received from a consumer concerning her 32 month old daughter with reactions to ATTENUVAX and MERUVAX. Consumer stated that "when her daughter was given RECOMBIVAX HB (lot # unknown), she had trouble getting her words out and was stuttering". Consumer also stated that her daughter was not going to finish the series for RECOMBIVAX HB. The patient was also vaccinated with a 0.5 ml dose of VARIVAX (Merck) (WAES#1001USA01886) and was diagnosed with pneumonia after vaccination. Upon internal review she was stuck in a couple of words/had trouble getting her words out was considered to be other important medical event. No further information is available. This is a consolidation of two reports concerning the same patient. It has been determined that WAES # 1011USA00486 is a duplicate of WAES # 1001USA00713. Therefore, WAES # 1011USA00486 is being deleted from our files and the reports consolidated into WAES # 1001USA00713.
Had left deltoid pain starting within 24 hours of vaccination and have had left upper arm pain that is daily, unrelenting and made worse with left arm extension and any behind back work and any lifting and gets worse as each day goes on. I am almost four weeks out know and it is not going away
Pt had entire (R) leg swell circumferentially secondary to DaPT hot to touch evolved over 5 day period. Txed BENADRYL & KEFLEX. Father EPIPEN for fire auto.
Okay left voicemail with cdc and wrote this email  I?m not sure how to report symptoms I had after taking the jannsen vaccine March 6. Because of the new reports I thought it may be helpful.  To begin in late nov 2020 my roommate was confirmed covid.  I was exposed tremendously and never tested because if I did not get it from him, I was immune.  He was very ill.  He talked of getting head pains as well.  I got sick for a weekend but not super ill.  Tired, headache and head pains in one spot.   After my vaccine I felt the same illness but ran a fever with the shot.  My main recognition was I had the exact same head pains, same exact spot I had when I?m sure I had Covid. 1 unusual symptom I had after the shot was I felt like I had a 4? metal plate wrapped around my arm where I got the shot for a half day.   Hope this helps.
Possible Pfizer vaccine to recipient.  2nd dose. This consent form filled out by recipient  was marked as Moderna for first vaccine.
Fatigue; painful joints; This is a spontaneous report from a contactable nurse (patient). A non pregnant 76-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL9263 and expiration date was not reported), via an unspecified route of administration, administered in Arm Left on 29Jan2021 (at the age of 76-years-old) at dose 1, single for covid-19 immunization. Other medical history included HBP (blood pressure high), osteoporosis, history of pneumonia and valley fever resulting in DOE (dyspnea on exertion). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, patient has not been tested for COVID-19. Concomitant medications included losartan; amlodipine; ergocalciferol (VIT D); cyanocobalamin (VIT B12); iron and biotin. The patient previously took macrodantin and experienced drug allergy and experienced pyrexia.  The patient experienced fatigue, painful joints in 2021. The outcome of the events was recovered in Feb2021.  No follow-up attempts are needed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021357652 Same reporter/patient, different vaccine dose number and similar event.
Pain at inhection site, fatigue, chills, fever 101.6, upset stomach, headache
Extreme headache; got the results of a CT scan and there is something wrong; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: The reporter is the patient.  A 90-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in Mar2023 as dose 5 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose number: 4, Unknown manufacturer), for Covid-19 immunization; Covid-19 vaccine (Dose number: 3, Unknown manufacturer), for Covid-19 immunization; Covid-19 vaccine (Dose number: 2, Unknown manufacturer), for Covid-19 immunization; Covid-19 vaccine (Dose number: 1, Unknown manufacturer), for Covid-19 immunization. The following information was reported: HEADACHE (non-serious) with onset Mar2023, outcome "unknown", described as "Extreme headache"; COMPUTERISED TOMOGRAM ABNORMAL (non-serious) with onset Mar2023, outcome "unknown", described as "got the results of a CT scan and there is something wrong". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: It was reported that patient had a Pfizer 5th shot (Confirmed as COVID-19 vaccine) the last week of Mar and had extreme headache and yesterday (unspecified date) got the results of a CT scan and there was something wrong that is definitely from the Pfizer COVID shot and wanted to find out what to do for it. Extreme headache; gone for 4 weeks; still had the headache. Reported that, by 24 hours had an extreme headache. The headache was gone on for 4 weeks, this week and had CT scan everything was correct but still had the headache and told that Pfizer recommends a product called Zavzpret but noticed that it was like 500 dollars. Patient called in seeking assistance with the medication Zavzpret. Patient doctor said it was a rebound from the Pfizer. And told that Pfizer recommends that Zavzpret shot. Note: The patient's date of birth and address was not provided during the call. Patient mentioned that she had her fifth COVID shot last week of Mar and immediately had headaches. She mentioned that she had a CT Scan to make sure that there were not any other problems and that now she was going to be recommended to take Zavzpret. She mentioned that Zavzpret is very expensive and that she cannot afford it. Caller wanted to get some recommendations.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
No one was injured as a result of the breakage/ No additional AE; VAXNEUVANCE broke during administration to a patient; VAXNEUVANCE broke at the top of the syringe, right at the luer lock, while it was being administered; the patient received "most" of the dose that was being administered; This spontaneous report was received from a registered nurse referring to a 4-month-old patient of unspecified gender. The patient's medical history, concurrent conditions, concomitant therapies and previous drug reactions or allergies were not reported.   On 23-OCT-2023, the patient was vaccinated with a dose of pneumococcal 15v conj vaccine (CRM197) (VAXNEUVANCE) 0.5 milliliters (mL) injection administered intramuscularly (IM) injection, at a dosage of 0.5 mL (dose number, vaccination scheme frequency, and anatomical site of vaccination were not reported; lot# X020693 has been verified to be valid, expiration date reported and established as 18-OCT-2025) for prophylaxis (reported as vaccination). It was reported that they inspected the pneumococcal 15v conj vaccine (CRM197) (VAXNEUVANCE) prior to the administration, they did not see any defects and the syringe was intact; however, the syringe broke into 2 pieces at the top, right at the luer lock while giving the vaccine (syringe issue, poor quality device used).   The reporter stated that they believed the patient received "most" of the dose that was being administered (incorrect dose administered). No one was injured as a result of the breakage, and no additional adverse event was reported (no adverse event).
This non-serious spontaneous case, initially received on 20-Dec-2017, was reported by other health professional and concerns a 43-year-old adult female pregnant patient of weight 129 pounds and 59 inches. The patient's history included, 3 previous pregnancies in which two are full term live births and one spontaneous abortion. The patient had no family history of major congenital malformations. The patient had no habit of tobacco, alcohol or illicit drug use. The historical conditions included chlamydial infection and UTI (urinary tract infection). The historical drugs included ZITHROMAX for chlamydia and MACROBID for UTI. The patient LMP (last menstrual period) was reported as 28-May-2017. The concomitant medication included VITAFOL-ONE. On 17-Aug-2017, cystic fibrosis mutation analysis was normal (no major congenital malformations noted). On 25-Aug-2017, first trimester screen and Panorama performed was normal (no major congenital malformations noted). On 22-Sep-2017, amniocentesis performed was normal (no major congenital malformations noted). On 28-Sep-2017, the patient was administered with AFLURIA QUADRIVALENT (dose, route of administration, anatomical location, batch number: 00644623A (as reported), expiry date: not reported), at 17th week of pregnancy (explicitly considered as vaccine exposure during pregnancy). The patient had no adverse events. The EDD (estimated date of delivery) was reported as 04-Mar-2018.
Pt reported that after she received Td vaccine she had to see a doctor due to local pain and swelling to injection site. See physician report.
Pt recvd pneumococcal vax & on 10DEC91 & devel nausea, vomiting, & lt arm soreness & a 5 by 3 inch swelling @ inject site; it was warm to touch & very tender; devel fever & myalgia; pt taken to MD office erythema noted;
Redness and pain lasting longer that 3 days (Days 1-6)  Small painless lump with some redness on 7th day of injection
Started having tenderness, erythema, and pruritis on left arm at vaccine site, worsened over next few days, even after ice and hydrocortisone cream, went to see provider on 8/5/13 and lateral aspect of upper arm from deltoid to distal humerus was warm, erythematous, coalescing patches, tender. No fevers or any other symptoms.
Narrative:  66 yo M w/ hx of 3v CAD on LHC 9/2020 receiving medical management, CKD IV, PAD s/p SFA stent, DMII, HTN died on 9/12/2021. No info provided on circumstances of pt's death. Pt had received covid vaccines on 2/17/2021 & 3/22/2021. This death is likely not related to the vaccinations due to comorbidities, age, length of time from vaccine administration.
Patient noticed bumps, starting itching on left arm, left upper chest, and face, decided to go to the ER.
Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-JUL-2022; No adverse event; Patient administered the vaccine after the 30 days by used; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 days by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-JUL-2022) and NO ADVERSE EVENT (No adverse event) in a 52-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 22-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 22-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 days by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-JUL-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 days by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-JUL-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 days by used) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-JUL-2022).    No concomitant medications were reported. The vial was initially stored in the refrigerator on 04-Jun-2022. The date of vaccine administration was from 4-Jun-2022 until 26-Jul-2022. The vial did not undergo any temperature excursions. Patient received half dose. No treatment medications were reported.